Get started
Work

OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients

Year: 2017
Type: conference-abstract
DOI: 10.1016/j.jtho.2016.11.343
Authors: Marcin Kowanetz, Wei Zou, David Shames, Craig Cummings, Naiyer Rizvi, Alexander Spira, Garrett Frampton, Vincent Leveque, Susan Flynn, Simonetta Mocci, Geetha Shankar, Roel Funke, Marcus Ballinger, Daniel Waterkamp, Daniel Chen, Alan Sandler, Garret Hampton, Lukas Amler, Priti Hegde, Matthew Hellmann
Institutions: Genentech, Columbia University, Virginia Cancer Specialists, The US Oncology Network, Foundation Medicine (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2568927397
Cites:
Cited by: 86
Related to: 10